Tempest Therapeutics appoints Nancy Freda-Smith to board, names her audit committee chair
Bitget2026/09/28 20:06- Tempest Therapeutics appointed Nancy Freda-Smith to its board of directors.
- Freda-Smith will serve as chair of the audit committee.
- She most recently served as chief audit and risk officer at Ralph Lauren.
- Earlier roles include managing director at Deloitte & Touche LLP.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Chip Expansion Continues, Applied Materials (AMAT.US) Q1 Revenue Guidance Exceeds Expectations
Applied Materials reported Q4 revenue of $10.41 billion, surpassing expectations and setting a record for the full year. Its Q1 guidance also exceeded forecasts, driven by strong demand for AI chips, and the stock rose about 3% after hours.
Saba Capital Management reports acquisition of $755,308.44 in Mexico Fund common shares
Juniper Investment Reports Acquisition of $5.11 Million in Orthofix Medical Common Shares
The U.S. fiscal deficit in October expanded by 42% year-on-year to $404 billion, with the current fiscal year gap expected to reach $2.2 trillion.
Data released by the U.S. Treasury Department on Thursday showed that, due to increased government spending and decreased tax revenue, the U.S. fiscal deficit reached $404 billions in October, expanding by 42% compared to the same period last year.
Crypto prices
More
